Soleus Capital Management, L.P. Surmodics Inc Transaction History

Soleus Capital Management, L.P.

$1.21 Billion
Q1 2025

A detailed history of Soleus Capital Management, L.P. transactions in Surmodics Inc stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 789,060 shares of SRDX stock, worth $23.4 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares

789,060

Previous 394,060 100.24%

Holding current value

$23.4 Million

Previous $15.6 Million 54.38%

% of portfolio

1.99%

Previous 1.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$26.71 - $39.71 $10.6 Million - $15.7 Million	395,000 Added 100.24%	789,060 $24.1 Million
Q4 2024 Feb 14, 2025	SELL	$37.5 - $40.13 $9.14 Million - $9.78 Million	-243,638 Reduced 38.21%	394,060 $15.6 Million
Q3 2024 Nov 14, 2024	SELL	$38.47 - $42.24 $5.54 Million - $6.09 Million	-144,079 Reduced 18.43%	637,698 $24.7 Million
Q2 2024 Aug 14, 2024	SELL	$25.39 - $42.1 $483,501 - $801,710	-19,043 Reduced 2.38%	781,777 $32.9 Million
Q1 2024 May 15, 2024	BUY	$27.44 - $35.56 $799,052 - $1.04 Million	29,120 Added 3.77%	800,820 $23.5 Million
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $13.1 Million - $17.7 Million	-459,162 Reduced 37.3%	771,700 $28.1 Million
Q3 2023 Nov 14, 2023	SELL	$28.28 - $38.36 $3 Million - $4.07 Million	-105,976 Reduced 7.93%	1,230,862 $39.5 Million
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $7.85 Million - $13.9 Million	444,160 Added 49.76%	1,336,838 $41.9 Million
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $2.01 Million - $4.52 Million	117,367 Added 15.14%	892,678 $20.3 Million
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $201,163 - $254,939	6,833 Added 0.89%	775,311 $26.5 Million
Q3 2022 Nov 14, 2022	BUY	$28.84 - $38.92 $3.1 Million - $4.18 Million	107,474 Added 16.26%	768,478 $23.4 Million
Q2 2022 Aug 15, 2022	BUY	$33.25 - $45.11 $3.41 Million - $4.63 Million	102,564 Added 18.37%	661,004 $24.6 Million
Q1 2022 May 16, 2022	BUY	$40.68 - $49.72 $1.04 Million - $1.28 Million	25,683 Added 4.82%	558,440 $25.3 Million
Q4 2021 Feb 14, 2022	BUY	$43.21 - $57.6 $6.53 Million - $8.71 Million	151,235 Added 39.64%	532,757 $25.7 Million
Q3 2021 Nov 15, 2021	BUY	$52.8 - $60.32 $5.44 Million - $6.22 Million	103,118 Added 37.04%	381,522 $21.2 Million
Q2 2021 Aug 16, 2021	BUY	$51.29 - $59.15 $6.37 Million - $7.34 Million	124,129 Added 80.46%	278,404 $15.1 Million
Q1 2021 May 17, 2021	BUY	$42.18 - $56.07 $2.59 Million - $3.44 Million	61,300 Added 65.93%	154,275 $8.65 Million
Q4 2020 Feb 16, 2021	BUY	$35.18 - $43.52 $552,044 - $682,915	15,692 Added 20.3%	92,975 $4.05 Million
Q3 2020 Nov 13, 2020	BUY	$37.98 - $48.72 $1.26 Million - $1.62 Million	33,305 Added 75.73%	77,283 $3.01 Million
Q2 2020 Aug 14, 2020	BUY	$31.07 - $44.74 $1.37 Million - $1.97 Million	43,978 New	43,978 $1.9 Million

Others Institutions Holding SRDX

# of Institutions

143

Shares Held

12.1M

Call Options Held

31.3K

Put Options Held

17.9K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $415M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. Surmodics Inc Transaction History